Showing 871-880 of 21415 results for "".
- Breaking Down the TUXEDO-2 Findings: Antithrombotic Choices After PCIhttps://reachmd.com/news/breaking-down-the-tuxedo-2-findings-antithrombotic-choices-after-pci/2484417/TUXEDO-2 shows prasugrel reduced one‑year ischemic events and major bleeding compared with ticagrelor in patients with diabetes undergoing drug‑eluting stent placement — a finding that should influence P2Y12 selection for high‑risk diabetic PCI patients. In a randomi
- FDA's Regulatory Green Light for Gene-Editing Therapy in PH1 Spurs New Hope in Renal Disease Treatmenthttps://reachmd.com/news/fdas-regulatory-green-light-for-gene-editing-therapy-in-ph1-spurs-new-hope-in-renal-disease-treatment/2484579/The FDA has cleared the YOLT-203 pivotal trial, enabling a first‑in‑class in vivo gene‑editing pivotal study for Primary Hyperoxaluria Type 1 (PH1).
- Emergency Departments Frequently Miss Signs of Epilepsy in Childrenhttps://reachmd.com/news/emergency-departments-frequently-miss-signs-of-epilepsy-in-children/2462931/A subtle type of seizure goes undetected two-thirds of the time in pediatric emergency departments, a new study shows. The work focuses on “nonm
- MFRF Plus Botulinum Toxin Shows Potential for Periorbital Aginghttps://reachmd.com/news/mfrf-plus-botulinum-toxin-shows-potential-for-periorbital-aging/2488623/Combining microneedle fractional radiofrequency (MFRF) with botulinum toxin type A (BoNT/A) was associated with sustained improvement in crow’s feet and selected measures of skin quality through 24 weeks in a small retrospective cohort study published in Clinical, Cosmetic and Investigational
- Cherry Angiomas Linked to NF1-Related Vascular Changes: Studyhttps://reachmd.com/news/cherry-angiomas-linked-to-nf1-related-vascular-changes-study/2488158/Cherry angiomas may be a previously underrecognized vascular manifestation of neurofibromatosis type 1 (NF1), according to findings from a prospective comparative study in JAMA Dermatology. Investigators evaluated 259 participants (102 individuals with confirmed NF1 and 157 contro
- Monophasic HA Shows Longer-Term Benefit in Nasolabial Fold Correctionhttps://reachmd.com/news/monophasic-ha-shows-longer-term-benefit-in-nasolabial-fold-correction/2488118/A randomized study comparing 2 types of hyaluronic acid (HA) dermal fillers found similar early improvements in moderate-to-severe nasolabial folds (NLFs), with outcomes favoring monophasic HA at 36 weeks. Galinde et al conducted a randomized, controlled, double-blinded, intraindividual st
- Virtual Reality Training for Chronic Low Back Pain: Comparative Reviewhttps://reachmd.com/news/virtual-reality-training-for-chronic-low-back-pain-comparative-review/2487907/Key Takeaways Shooting games and VR-based equestrian training were associated with greater pain reduction than all control types, while multicomponent mixed games were superior to placebo controls only; shooting games ranked highest for pain. No interv
- Prediagnostic Metabolites Linked To Future Liver Cancer Risk In 12 Cohortshttps://reachmd.com/news/prediagnostic-metabolites-linked-to-future-liver-cancer-risk-in-12-cohorts/2487852/Key Takeaways Across 1,485 metabolites, broad associations were observed for future HCC, while no metabolites remained significant for ICC after false discovery rate correction. Pathway enrichment differed by cancer type, with HCC signals in methylhist
- Pancreatic Ductal Adenocarcinoma with Autoimmune Pancreatitishttps://reachmd.com/news/pancreatic-ductal-adenocarcinoma-with-autoimmune-pancreatitis/2487106/Key Takeaways Type 1 autoimmune pancreatitis in a 50-year-old man was followed over six months by recognition of a pancreatic head mass. EUS-guided fine-needle aspiration of the mass showed pancreatic ductal adenocarcinoma with IgG4-positive plasma cel
- Most Patients With Advanced Cancer Still Aren't Getting Genomic Testinghttps://reachmd.com/news/most-patients-with-advanced-cancer-still-arent-getting-genomic-testing/2486838/Key Takeaways NGS use increased from 2018 to 2022 across all five tumor types, but testing remained incomplete. Longer time to testing was associated with lower socioeconomic status, Black race in several cancers, Hispanic ethnicity in several cancers,